Clinical Trial · NCT04758416

A Phase II, Single-center STudy on the vAlue of Non-invasive Dual-Pet(18F-FES PET and 68Ga-HER2-Affibody PET)InformatiOn IN Subtype of Metastatic Breast Cancer(MBC)

Overview

Study on the Value of Non-invasive Dual-Pet(18F-FES PET and 68Ga-HER2-Affibody PET) Information in Subtype of Metastatic Breast Cancer

Sponsor

Fudan University

Phase

N/A

Contacts

Xichun Hu, MD, PhD

huxicun@gmail.com

64175590 ext 5006

Jian Zhang, M.D.

syner2000@163.com

64175590 ext 85000

ClinicalTrials.gov

NCT04758416